Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 119.00
+6.00 (5.31%)
Feb 16, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 8.47 billion as of February 13, 2026. Its market cap has decreased by -54.35% in one year.
Market Cap
8.47B
Enterprise Value
6.13B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
119.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 8.47B, a decrease of -32.70%. That is a compound annual growth rate of -21.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 8.47B | 13.67% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qol Holdings | 73.91B |
| Cawachi | 69.91B |
| Shinnihonseiyaku | 44.03B |
| Heartseed | 44.02B |
| YAKUODO HOLDINGS | 40.46B |
| Astena Holdings | 19.62B |
| Ohki Healthcare Holdings | 18.12B |
| Medical System Network | 15.64B |